Literature DB >> 26719121

Clinical implications of positive margins following non-small cell lung cancer surgery.

Jarrod D Predina1, Jane Keating1, Neil Patel1, Sarah Nims1, Sunil Singhal1.   

Abstract

Positive margins following pulmonary resection of non-small cell lung cancer (NSCLC) occur in approximately 5-15% of patients undergoing a curative procedure. The presence of positive margins negatively impacts long-term outcomes by setting the stage for local and potentially distant disease recurrence. Despite major clinical ramifications, there are very few dedicated reports that examine the implications of positive margins following surgery for NSCLC. Furthermore, published series are typically retrospective studies from single institutions. In this review we analyze published data with special consideration of four pertinent questions: (i) what are the long term outcomes of a positive margin following pulmonary resection?, (ii) is intraoperative margin assessment by frozen section reliable?, (iii) what is the optimal distance of the tumor margin to the surgical margin?, and (iv) should adjuvant chemotherapy and/or radiation therapy be used in the setting of a positive surgical margin?
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  local recurrence; non-small cell lung cancer (NSCLC); positive margin

Mesh:

Year:  2015        PMID: 26719121     DOI: 10.1002/jso.24130

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  11 in total

1.  Comparative Experience of Short-wavelength Versus Long-wavelength Fluorophores for Intraoperative Molecular Imaging of Lung Cancer.

Authors:  Gregory T Kennedy; Feredun S Azari; Ashley Chang; Bilal Nadeem; Elizabeth Bernstein; Alix Segil; Azra Din; Isvita Marfatia; Charuhas Desphande; Olugbenga Okusanya; Jane Keating; Jarrod Predina; Andrew Newton; John C Kucharczuk; Sunil Singhal
Journal:  Ann Surg       Date:  2022-07-15       Impact factor: 13.787

2.  A Prostate-Specific Membrane Antigen-Targeted Near-Infrared Conjugate for Identifying Pulmonary Squamous Cell Carcinoma during Resection.

Authors:  Gregory T Kennedy; Feredun S Azari; Elizabeth Bernstein; Bilal Nadeem; Ashley E Chang; Alix Segil; Neil Sullivan; Isvita Marfatia; Azra Din; Charuhas Desphande; John C Kucharczuk; Philip S Low; Sunil Singhal
Journal:  Mol Cancer Ther       Date:  2022-04-01       Impact factor: 6.009

3.  The preoperative hemoglobin, albumin, lymphocyte, and platelet score is a prognostic factor for non-small cell lung cancer patients undergoing adjuvant chemotherapy: a retrospective study.

Authors:  Sheng Wei; Jingjing Shao; Jinming Wang; Gaoren Wang
Journal:  Ann Transl Med       Date:  2022-04

4.  Delivery of eupenifeldin via polymer-coated surgical buttresses prevents local lung cancer recurrence.

Authors:  Zeinab Y Al Subeh; Ngoc-Quynh Chu; Jeremy T Korunes-Miller; Lillian L Tsai; Tyler N Graf; Yin P Hung; Cedric J Pearce; Mark W Grinstaff; Aaron H Colby; Yolonda L Colson; Nicholas H Oberlies
Journal:  J Control Release       Date:  2021-01-21       Impact factor: 9.776

5.  An open label trial of folate receptor-targeted intraoperative molecular imaging to localize pulmonary squamous cell carcinomas.

Authors:  Jarrod D Predina; Andrew D Newton; Leilei Xia; Christopher Corbett; Courtney Connolly; Michael Shin; Lydia Frezel Sulyok; Leslie Litzky; Charuhas Deshpande; Shuming Nie; Sumith A Kularatne; Philip S Low; Sunil Singhal
Journal:  Oncotarget       Date:  2018-02-05

6.  Evaluation of Aminolevulinic Acid-Derived Tumor Fluorescence Yields Disparate Results in Murine and Spontaneous Large Animal Models of Lung Cancer.

Authors:  Jarrod D Predina; Jeffrey Runge; Andrew Newton; Michael Mison; Leilei Xia; Christopher Corbett; Michael Shin; Lydia Frenzel Sulyok; Amy Durham; Shuming Nie; Sunil Singhal; David Holt
Journal:  Sci Rep       Date:  2019-05-21       Impact factor: 4.379

7.  Survival benefit and toxicity profile of adjuvant icotinib for patients with EGFR mutation-positive non-small cell lung carcinoma: a retrospective study.

Authors:  Ziqing Zeng; Bo Yan; Yulong Chen; Lianmin Zhang; Jianquan Zhu; Fan Yang; Feng Wei; Terence Chi Chun Tam; Diego Kauffmann-Guerrero; Ross Andrew Soo; Xiubao Ren; Jian You
Journal:  Transl Lung Cancer Res       Date:  2020-12

8.  Positive Surgical Margins in the 10 Most Common Solid Cancers.

Authors:  Ryan K Orosco; Viridiana J Tapia; Joseph A Califano; Bryan Clary; Ezra E W Cohen; Christopher Kane; Scott M Lippman; Karen Messer; Alfredo Molinolo; James D Murphy; John Pang; Assuntina Sacco; Kathryn R Tringale; Anne Wallace; Quyen T Nguyen
Journal:  Sci Rep       Date:  2018-04-09       Impact factor: 4.379

Review 9.  The complementary value of intraoperative fluorescence imaging and Raman spectroscopy for cancer surgery: combining the incompatibles.

Authors:  L J Lauwerends; H Abbasi; T C Bakker Schut; P B A A Van Driel; J A U Hardillo; I P Santos; E M Barroso; S Koljenović; A L Vahrmeijer; R J Baatenburg de Jong; G J Puppels; S Keereweer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2022-02-01       Impact factor: 10.057

10.  Predictive value of the hemoglobin, albumin, lymphocyte, and platelet (HALP) score and lymphocyte-to-monocyte ratio (LMR) in patients with non-small cell lung cancer after radical lung cancer surgery.

Authors:  Baoqian Zhai; Jia Chen; Jiacheng Wu; Lei Yang; Xiaoli Guo; Jingjing Shao; Hong Xu; Aiguo Shen
Journal:  Ann Transl Med       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.